These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12357176)

  • 21. PRavastatin Versus FlUVastatin After Statin Intolerance: The PRUV-Intolerance Study With Propensity Score Matching.
    Roh JW; Chun KH; Kang M; Lee CJ; Oh J; Shim CY; Ahn CM; Kim JS; Kim BK; Park S; Chang HJ; Hong GR; Ko YG; Kang SM; Choi D; Ha JW; Hong MK; Jang Y; Lee SH
    Am J Med; 2019 Nov; 132(11):1320-1326.e1. PubMed ID: 31278931
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Development of tachyphylaxis among patients taking HMG CoA reductase inhibitors.
    Cromwell WC; Ziajka PE
    Am J Cardiol; 2000 Nov; 86(10):1123-7. PubMed ID: 11074211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.
    Conforti A; Magro L; Moretti U; Scotto S; Motola D; Salvo F; Ros B; Leone R
    Drug Saf; 2006; 29(12):1163-72. PubMed ID: 17147462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rhabdomyolysis secondary to hyponatraemia.
    Lara Aguayo P; de la Fuente Martos C; Morán Fernández E; Soriano Rodríguez F; Rojas Amezcua M; Aguilar Alonso E
    Nefrologia; 2011; 31(4):500-2. PubMed ID: 21738260
    [No Abstract]   [Full Text] [Related]  

  • 25. Updated clinical safety experience with fluvastatin.
    Jokubaitis LA
    Am J Cardiol; 1994 May; 73(14):18D-24D. PubMed ID: 8198019
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Muscular adverse effects of statins.
    Prescrire Int; 2003 Feb; 12(63):21. PubMed ID: 12602397
    [No Abstract]   [Full Text] [Related]  

  • 27. Autoimmune hepatitis after treatment with fluvastatin.
    Castiella A; Fernandez J; Zapata E
    Liver Int; 2007 May; 27(4):592. PubMed ID: 17403199
    [No Abstract]   [Full Text] [Related]  

  • 28. A literature search on pharmacokinetic drug interactions of statins and analysis of how such interactions are reflected in package inserts in Japan.
    Saito M; Hirata-Koizumi M; Urano T; Miyake S; Hasegawa R
    J Clin Pharm Ther; 2005 Feb; 30(1):21-37. PubMed ID: 15659001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of fluvastatin for safely lowering atherogenic lipids in renal transplant patients receiving cyclosporine.
    Holdaas H; Hartmann A; Stenstrøm J; Dahl KJ; Borge M; Pfister P
    Am J Cardiol; 1995 Jul; 76(2):102A-106A. PubMed ID: 7604781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fluvastatin as co-medication in heart transplant recipients with elevated creatine-kinase.
    Sadoni S; Kaczmarek I; Delgado O; Schmöckel M; Reichart B; Meiser B
    Transplant Proc; 2007 Mar; 39(2):558-9. PubMed ID: 17362781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute pancreatitis induced by fluvastatin therapy.
    Tysk C; Al-Eryani AY; Shawabkeh AA
    J Clin Gastroenterol; 2002; 35(5):406-8. PubMed ID: 12394230
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Creatine kinase elevation caused by a combination of fluvastatin and telmisartan in a patient heterozygous for the CYP2C9*3 and ABCC2 -24C > T variants: a case report.
    Meyer zu Schwabedissen HE; Siegmund W; Kroemer HK; Rollnik JD
    BMC Res Notes; 2014 Oct; 7():688. PubMed ID: 25280537
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Incidence of skeletal muscle disorders after statins' treatment: consequences in clinical and EMG picture.
    Drobny M; Pullmann R; Odalos I; Skerenova M; Saniova B
    Neuro Endocrinol Lett; 2014; 35(2):123-8. PubMed ID: 24878976
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asymptomatic statin-induced rhabdomyolysis after long-term therapy with the hydrophilic drug pravastatin.
    Schindler C; Thorns M; Matschke K; Tugtekin SM; Kirch W
    Clin Ther; 2007 Jan; 29(1):172-6. PubMed ID: 17379057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluvastatin treatment is not associated with an increased incidence of cancer.
    Stein EA; Corsini A; Gimpelewicz CR; Bortolini M; Gil M
    Int J Clin Pract; 2006 Sep; 60(9):1028-34. PubMed ID: 16939542
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Statins and risk of polyneuropathy: a case-control study.
    Gaist D; Jeppesen U; Andersen M; García Rodríguez LA; Hallas J; Sindrup SH
    Neurology; 2002 May; 58(9):1333-7. PubMed ID: 12011277
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of the magnitude of lipid lowering on risk of elevated liver enzymes, rhabdomyolysis, and cancer: insights from large randomized statin trials.
    Alsheikh-Ali AA; Maddukuri PV; Han H; Karas RH
    J Am Coll Cardiol; 2007 Jul; 50(5):409-18. PubMed ID: 17662392
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [High therapeutic effect and safety of fluvastatin].
    Pharm Unserer Zeit; 2003; 32(6):516-7. PubMed ID: 14639833
    [No Abstract]   [Full Text] [Related]  

  • 39. Chronic cough as a complication of treatment with statins: a case report.
    Psaila M; Fsadni P; Montefort S
    Ther Adv Respir Dis; 2012 Aug; 6(4):243-6. PubMed ID: 22761129
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Should high creatine kinase discourage the initiation or continuance of statins for the treatment of hypercholesterolemia?
    Glueck CJ; Rawal B; Khan NA; Yeramaneni S; Goldenberg N; Wang P
    Metabolism; 2009 Feb; 58(2):233-8. PubMed ID: 19154957
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.